Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for NATR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 82.50M
March 31, 2026 87.58M
December 31, 2025 93.89M
September 30, 2025 95.55M
June 30, 2025 81.34M
March 31, 2025 86.49M
December 31, 2024 84.70M
September 30, 2024 78.70M
June 30, 2024 68.70M
March 31, 2024 77.77M
December 31, 2023 82.37M
September 30, 2023 76.04M
June 30, 2023 68.97M
March 31, 2023 65.72M
December 31, 2022 60.03M
September 30, 2022 56.98M
June 30, 2022 56.34M
March 31, 2022 66.54M
December 31, 2021 86.18M
September 30, 2021 75.54M
June 30, 2021 74.90M
March 31, 2021 91.25M
December 31, 2020 92.07M
September 30, 2020 82.26M
June 30, 2020 70.26M
Date Value
March 31, 2020 64.14M
December 31, 2019 53.63M
September 30, 2019 50.53M
June 30, 2019 46.34M
March 31, 2019 45.40M
December 31, 2018 50.64M
September 30, 2018 47.86M
June 30, 2018 46.90M
March 31, 2018 42.30M
December 31, 2017 42.91M
September 30, 2017 47.69M
June 30, 2017 31.82M
March 31, 2017 34.84M
December 31, 2016 34.06M
September 30, 2016 42.23M
June 30, 2016 43.22M
March 31, 2016 48.22M
December 31, 2015 43.19M
September 30, 2015 45.67M
June 30, 2015 48.00M
March 31, 2015 52.63M
December 31, 2014 61.24M
September 30, 2014 72.28M
June 30, 2014 70.58M
March 31, 2014 73.48M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Cyanotech Corp. 1.094M
Mannatech, Inc. 6.252M
Natural Alternatives International, Inc. 9.196M
USANA Health Sciences, Inc. 168.56M
LifeVantage Corp. 14.92M